0001209191-20-015654.txt : 20200303 0001209191-20-015654.hdr.sgml : 20200303 20200303185426 ACCESSION NUMBER: 0001209191-20-015654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200303 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heron Patrick J CENTRAL INDEX KEY: 0001365617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39231 FILM NUMBER: 20684826 MAIL ADDRESS: STREET 1: 550 HAMILTON AVE., SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO COMMERCE SQUARE STREET 2: 2001 MARKET STREET, 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: TWO COMMERCE SQUARE STREET 2: 2001 MARKET STREET, 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-03 0 0001787297 Passage BIO, Inc. PASG 0001365617 Heron Patrick J 601 UNION STREET SEATTLE WA 98101 1 0 1 0 Common Stock 2020-03-03 4 C 0 2977242 A 2977242 I By Frazier Life Sciences IX, L.P. Common Stock 2020-03-03 4 C 0 1049175 A 4026417 I By Frazier Life Sciences IX, L.P. Common Stock 2020-03-03 4 C 0 432802 A 4459219 I By Frazier Life Sciences IX, L.P. Common Stock 2020-03-03 4 P 0 550000 18.00 A 5009219 I By Frazier Life Sciences IX, L.P. Series A-1 Preferred Stock 2020-03-03 4 C 0 2977242 0.00 D Common Stock 2977242 0 I By Frazier Life Sciences IX, L.P. Series A-2 Preferred Stock 2020-03-03 4 C 0 1049175 0.00 D Common Stock 1049175 0 I By Frazier Life Sciences IX, L.P. Series B Preferred Stock 2020-03-03 4 C 0 432802 0.00 D Common Stock 432802 0 I By Frazier Life Sciences IX, L.P. Each share of the issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on March 3, 2020. These securities are held of record by Frazier Life Sciences IX, L.P. ("Frazier Life Sciences"), of which FHMLS IX, L.P. ("FHMLS L.P.") is the general partner. FHMLS IX, L.L.C. ("FHMLS LLC") is the general partner of FHMLS L.P. The reporting person and James N. Topper are the managing members of FHMLS LLC and may be deemed to have shared voting and dispositive power over the shares held by Frazier Life Sciences. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. /s/ Richard Morris as attorney-in-fact for Patrick J. Heron 2020-03-03